Hostname: page-component-cd9895bd7-8ctnn Total loading time: 0 Render date: 2024-12-23T16:39:22.807Z Has data issue: false hasContentIssue false
  • English
  • Français

Posttraumatic Stress Disorder: A Missed Link Between Psychiatric and Cardiovascular Morbidity?

Published online by Cambridge University Press:  07 November 2014

Gad Cotter ,
Olga Milo-Cotter ,
David Rubinstein  and
Eyal Shemesh
Get access Rights & Permissions [Opens in a new window]

Abstract

Posttraumatic stress disorder (PTSD) symptoms may develop as a result of an acute, life-threatening traumatic event. Such acute events are quite common in patients with cardiovascular illnesses (ie, a myocardial infarction, acute exacerbations of heart failure or edema). Indeed, PTSD symptoms have been described in a substantial minority of patients who had such events (10% to 25%), and have been shown to be associated with medical morbidity and with non-adherence to medications. This review summarizes available information about these symptoms in patients with cardiovascular illnesses. It also describes the importance of recognizing PTSD as a distinct psychiatric disorder (that can be addressed by specific treatments) and as an important compounding factor in studies of psychopathology in cardiovascular patients. In particular, an argument is made that the understanding of depressive disorders in patients with cardiovascular illnesses should incorporate conceptual and treatment information from the emotional trauma literature if indeed depressive and anxiety disorders are to be successfully treated in these patients. The authors conclude with a description of the challenges and promise of an effort to implement a clinical program to screen for PTSD symptoms in patients with cardiovascular illnesses, and with recommendations for future efforts.

Type
Review Articles
Information
CNS Spectrums , Volume 11 , Issue 2 , February 2006 , pp. 129 - 136
Copyright
Copyright © Cambridge University Press 2006

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

REFERENCES

1.Barth, JP, Schumacher, MMA, Herrmann-Lingen, CMD. Depression as a risk factor for mortality in patients with coronary heart disease: a meta-analysis. Psychosom Med. 2004:66;802–813.Google Scholar
2.van Melle, JPMD, de Jonge, PP, Spijkerman, TAMD, et al.Prognostic association of depression following myocardial infarction with mortality and cardiovascular events: a meta-analysis. Psychosom Med. 2004:66;814–822.Google Scholar
3.Berkman, LF, Blumenthal, J, Burg, M, et al.Effects of treating depression and low perceived social support on clinical events after myocardial infarction: the Enhancing Recovery in Coronary Heart Disease Patients (ENRICHD) Randomized Trial. JAMA. 2003:289;3106–3116.Google Scholar
4.Glassman, AH, O'Connor, CM, Califf, RM, et al.Sertraline treatment of major depression in patients with acute MI or unstable angina. JAMA. 2002:288;701–709.Google Scholar
5.Dobson, KS. A meta-analysis of the efficacy of cognitive therapy for depression. J Consult Clin Psychol. 1989:57;414–419.Google Scholar
6.Diagnostic and Statistical Manual of Mental Disorders. 4th ed. text rev. Washington, DC: American Psychiatric Association: 2000.Google Scholar
7.Shemesh, E, Stuber, ML. Posttraumatic stress responses in patients with life-threatening illnesses. CNS Spectr. 2006;2:xx–xx.Google Scholar
8.Billings, RF, Kearns, PM, Levene, DL. The influence of psychological factors on chest pain associated with myocardial infarction. Acta Med Scand Suppl. 1981;644:46–48.Google Scholar
9.Spindler, H, Pedersen, SS. Posttraumatic stress disorder in the wake of heart disease: prevalence, risk factors, and future research directions. Psychosom Med. 2005:67;715–723.Google Scholar
10.Kutz, I, Shabtai, H, Solomon, Z, Neumann, M, David, D. Post-traumatic stress disorder in myocardial infarction patients: prevalence study. Isr J Psychiatry Relat Sci. 1994:31;48–56.Google Scholar
11.Ginzburg, K, Solomon, Z, Bleich, A. Repressive coping style, acute stress disorder, and posttraumatic stress disorder after myocardial infarction. Psychosom Med. 2002:64;748–757.Google Scholar
12.Pedersen, SS, Middel, B, Larsen, ML. Posttraumatic stress disorder in first-time myocardial infarction patients. Heart Lung. 2003:32;300–307.CrossRefGoogle ScholarPubMed
13.Shemesh, E, Rudnick, A, Kaluski, E, et al.A prospective study of posttraumatic stress symptoms and nonadherence in survivors of a myocardial infarction (MI). Gen Hosp Psychiatry. 2001:23;215–222.Google Scholar
14.Shemesh, E, Yehuda, R, Milo, O, et al.Posttraumatic stress, nonadherence, and adverse outcome in survivors of a myocardial infarction. Psychosom Med. 2004:66;521–526.Google Scholar
15.Shemesh, E, Michovitz, M, Yehuda, R, et al.Symptoms of posttraumatic stress disorder in patients who had a myocardial infarction. Psychosomatics. In press.Google Scholar
16.Cotter, G., Shemesh, E, Zehavi, M, Dinur, I, Rudnick, A, Milo, O, Vered, Z, Krakover, R, Kaluski, E, Kornberg, A. Lack of aspirin effect: aspirin resistance or resistance to taking aspirin? Am Heart J. 2004:147;293–300.Google Scholar
17.Dew, MA, Kormos, RL, Roth, LH, Murali, S, DiMartini, A, Griffith, BP. Early post-transplant medical compliance and mental health predict physical morbidity and mortality one to three years after heart transplantation. J Heart Lung Transplant. 1999:18;549–562.Google Scholar
18.Shalev, AY, Sahar, T, Freedman, S, et al.A prospective study of heart rate response following trauma and the subsequent development of posttraumatic stress disorder. Arch Gen Psychiatry. 1998:55;553–559.Google Scholar
19.Nishith, P, Duntley, SP, Domitrovich, PP, Uhles, ML, Cook, BJ, Stein, PK. Effect of cognitive behavioral therapy on heart rate variability during REM sleep in female rape victims with PTSD. J Trauma Stress. 2003;16:247–250Google Scholar
20.Yehuda, R. Current status of cortisol findings in post-traumatic stress disorder. Psychiatr Clin North Am. 2002;25:341–368Google Scholar
21.Yehuda, R. Post-traumatic stress disorder. N Engl J Med. 2002:346;108–114.Google Scholar
22.Yehuda, R. Biology of posttraumatic stress disorder. J Clin Psychiatry. 2001;62(suppl 17):41–46.Google Scholar
23.Yehuda, R, Halligan, SL, Bierer, LM. Relationship of parental trauma exposure and PTSD to PTSD, depressive and anxiety disorders in offspring. J Psychiatr Res. 2001:35;261–270.Google Scholar
24.Yehuda, R, Teicher, MH, Trestman, RL, Levengood, RA, Siever, LJ. Cortisol regulation in posttraumatic stress disorder and major depression: a chronobiological analysis. Biol Psychiatry. 1996:40;79–88.Google Scholar
25.Hapke, U, Schumann, A, Rumpf, HJ, John, U, Konerding, U, Meyer, C. Association of smoking and nicotine dependence with trauma and posttraumatic stress disorder in a general population sample. J Nerv Ment Dis. 2005:193;843–846.Google Scholar
26.Breslau, N, Davis, GC, Schultz, LR. Posttraumatic stress disorder and the incidence of nicotine, alcohol, and other drug disorders in persons who have experienced trauma. Arch Gen Psychiatry. 2003:60;289–294.Google Scholar
27.McDermott, MM, Schmitt, B, Wallner, E. Ilmpact of medication nonadherence on coronary heart disease outcomes. A critical review. Arch Intern Med. 1997:157;1921–1929.Google Scholar
28.A randomized trial of propranolol in patients with acute myocardial infarction. I. Mortality results. JAMA. 1982:247;1707–1714.Google Scholar
29.Gallagher, EJ, Viscoli, CM, Horwitz, RI. The relationship of treatment adherence to the risk of death after myocardial infarction in women. JAMA. 1993:270;742–744.Google Scholar
30.Influence of adherence to treatment and response of cholesterol on mortality in the coronary drug project. N Engl J Med 1980:303;1038–1041.Google Scholar
31.Foa, EBPsychosocial treatment of posttraumatic stress disorder. J Clin Psychiatry. 2000:61 (suppl 5):43–48.Google Scholar
32.Friedman, MJ, Donnelly, CL, Mellman, TA. Pharmacotherapy for PTSD. Psychiatr Ann. 2003:33;57–62.Google Scholar
33.Brady, K, Pearlstein, T, Asnis, GM, et al.Efficacy and safety of sertraline treatment of posttraumatic stress disorder: a randomized controlled trial. JAMA. 2000:283;1837–1844.Google Scholar
34.Davidson, JR, Rothbaum, BO, van der Kolk, BA, Sikes, CR, Farfel, GM. Multicenter, double-blind comparison of sertraline and placebo in the treatment of posttraumatic stress disorder. Arch Gen Psychiatry. 2001:58;485–492.Google Scholar
35.Marshall, RD, Beebe, KL, Oldham, M, Zaninelli, R. Efficacy and safety of paroxetine treatment for chronic PTSD: a fixed-dose, placebo-controlled study. Am J Psychiatry. 2001;158:1982–1988.Google Scholar
36.Tucker, P, Zaninelli, R, Yehuda, R, Ruggiero, L, Dillingham, K, Pitts, CD. Paroxetine in the treatment of chronic posttraumatic stress disorder: results of a placebo-controlled, flexible-dosage trial. J Clin Psychiatry. 2001:62;860–868.Google Scholar
37.Wessely, S, Deahl, M. Psychological debriefing is a waste of time. Br J Psychiatry. 2003:183;12–14.Google Scholar
38.Rose, S, Bisson, J, Wessely, S. A systematic review of single-session psychological interventions (‘debriefing’) following trauma. Psychother Psychosom. 2003:72;176–184.Google Scholar
39.McFarlane, AC. Debriefing: care and sympathy are not enough. Med J Aust. 2003:178;533–534.Google Scholar
40.van Emmerik, AA, Kamphuis, JH, Hulsbosch, AM, Emmelkamp, PM. Single session debriefing after psychological trauma: a meta-analysis. Lancet. 2002:360;766–771.Google Scholar
41.Gist, R, Devilly, GJ. Post-trauma debriefing: the road too frequently travelled. Lancet. 2002:360;741–742.Google Scholar
42.Yehuda, R, ed. Psychological Trauma. Washington, DC: American Psychiatric Press; 1998.Google Scholar
43.Yehuda, R, ed. Treating Trauma Survivors with PTSD. Washington, DC: American Psychiatric Press: 2002.Google Scholar
44.Glassman, AH. Cardiovascular effects of antidepressant drugs: updated. J Clin Psychiatry. 1998;59(suppl 15):13–18.Google Scholar